Integral Health Asset Management’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-50,000
Closed -$12.1M 83
2024
Q1
$12.1M Sell
50,000
-20,000
-29% -$4.6M 1.13% 37
2023
Q4
$14.4M Sell
70,000
-40,000
-36% -$7.81M 1.96% 15
2023
Q3
$19.8M Buy
110,000
+84,000
+323% +$15.5M 2.74% 11
2023
Q2
$5M Buy
+26,000
New +$4.5M 0.62% 55
2021
Q4
Sell
-40,000
Closed -$4.78M 74
2021
Q3
$4.78M Sell
40,000
-30,000
-43% -$3.6M 1.37% 26
2021
Q2
$8.01M Buy
+70,000
New +$8.27M 2.21% 16
2021
Q1
Sell
-70,000
Closed -$6.84M 75
2020
Q4
$6.84M Sell
70,000
-30,000
-30% -$3M 2.04% 21
2020
Q3
$9.69M Buy
100,000
+10,000
+11% +$994K 2.96% 9
2020
Q2
$9.07M Buy
+90,000
New +$8.29M 2.72% 8

Other funds holding COR

Integral Health Asset Management's COR Position: Q2 2024 in Review

Integral Health Asset Management sold out of Cencora (COR) in Q2 2024, closing a stake of 50,000 shares — an estimated $12.1M sold.

Integral Health Asset Management first reported a position in COR in Q2 2020 and held it in 9 quarters. The position peaked at $19.8M in Q3 2023. 1,133 funds tracked by Wall St. Rank hold COR as of Q2 2024.

  • Integral Health Asset Management reported no remaining Cencora position as of Q2 2024 after selling out during the quarter.
  • Integral Health Asset Management sold 50,000 Cencora shares in Q2 2024, an estimated $12.1M.
  • Integral Health Asset Management first reported a position in Cencora in Q2 2020 and held it in 9 quarters.
  • Integral Health Asset Management's Cencora position peaked at $19.8M in Q3 2023.
  • 1,133 funds tracked by Wall St. Rank held Cencora as of Q2 2024.

Based on Integral Health Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.